# Latest earnings releases

Earnings press releases from every US-listed company, from SEC filings within minutes, with the headline numbers and an analysis. Newest first.

- [Sunrise Realty Trust (SUNS) Q3 2026 earnings](https://peardigitals.com/earnings/suns/2026-11-10/) — Nov 10, 5:30 PM ET — Distributable earnings of $3.2 million ($0.24 per share) were $0.05 million ($0.01 per share) below the $0.30 per share dividend paid, with net income of $2.9 million ($0.21 per share) reduced by approximately $0.06 per share of one-time merger-related expenses.
- [Elemental Royalty (ELE) Q3 2026 earnings](https://peardigitals.com/earnings/ele/2026-11-10/) — Nov 10, 5:22 PM ET — Revenue and adjusted EBITDA surged over 200% year-over-year, supported by strong contributions from Karlawinda, Bonikro, and Timok.
- [Actelis Networks (ASNS) Q3 2026 earnings](https://peardigitals.com/earnings/asns/2026-11-10/) — Nov 10, 5:17 PM ET — Revenue grew 68% year over year to $1.1 million, gross margin improved to 40%, and operating expenses fell 13%, narrowing the net loss by 37%.
- [SANUWAVE Health (SNWV) Q3 2026 earnings](https://peardigitals.com/earnings/snwv/2026-11-10/) — Nov 10, 5:09 PM ET — Revenue and operating performance declined sharply in Q3, driven by CMS reimbursement uncertainty and a secondary market for used systems.
- [Cumberland Pharmaceuticals (CPIX) Q3 2026 earnings](https://peardigitals.com/earnings/cpix/2026-11-10/) — Nov 10, 5:06 PM ET — Net income of $77.8 million driven by a $81.1 million gain on the divestiture of discontinued operations.
- [Himalaya Shipping (HSHP) Q3 2026 earnings](https://peardigitals.com/earnings/hshp/2026-11-10/) — Nov 10, 5:01 PM ET — Strong operational performance with TCE earnings significantly above market index and robust cash generation supporting shareholder distributions.
- [LiveOne (LVO) Q2 2027 earnings](https://peardigitals.com/earnings/lvo/2026-11-10/) — Nov 10, 5:00 PM ET — Record H1 results with $37.3M revenue and $7.8M Audio Adjusted EBITDA, but Q2 consolidated Adjusted EBITDA remains a loss.
- [Eastern (EML) Q3 2026 earnings](https://peardigitals.com/earnings/eml/2026-11-10/) — Nov 10, 5:00 PM ET — Net sales increased 36% YoY to $75.0 million, gross margin expanded to 23.9%, and adjusted EBITDA rose 119% to $7.6 million.
- [Dolphin Entertainment (DLPN) Q3 2026 earnings](https://peardigitals.com/earnings/dlpn/2026-11-10/) — Nov 10, 4:59 PM ET — Revenue hits a record $16.0 million, up 8.3% YoY, while net income turns positive to $0.2 million and adjusted EBITDA rises 42.9% to $1.6 million.
- [Gossamer Bio (GOSS) Q3 2026 earnings](https://peardigitals.com/earnings/goss/2026-11-10/) — Nov 10, 4:50 PM ET — Revenue surged on a termination gain, but cash declined and net loss widened due to non-recurring warrant remeasurement.
- [Hyliion Holdings (HYLN) Q3 2026 earnings](https://peardigitals.com/earnings/hyln/2026-11-10/) — Nov 10, 4:46 PM ET — Revenue and operating efficiency improved, with net loss narrowing and cash balance declining to $121.4 million.
- [Tandy Leather Factory (TLF) Q3 2026 earnings](https://peardigitals.com/earnings/tlf/2026-11-10/) — Nov 10, 4:44 PM ET — Sales and gross profit increased year-over-year, with net income turning positive from a prior-year loss.
- [KORU Medical Systems (KRMD) Q3 2026 earnings](https://peardigitals.com/earnings/krmd/2026-11-10/) — Nov 10, 4:43 PM ET — Revenue grew 12.4% year-over-year to $31.4 million, but adjusted EBITDA margin contracted by 2.2 percentage points to 13.9%.
- [Evolution Petroleum (EPM) Q1 2027 earnings](https://peardigitals.com/earnings/epm/2026-11-10/) — Nov 10, 4:36 PM ET — Adjusted EBITDA of $6.8 million increased 5% sequentially, but net income swung to a $3.0 million loss due to a $4.1 million unrealized derivative loss.
- [iBio (IBIO) Q1 2027 earnings](https://peardigitals.com/earnings/ibio/2026-11-10/) — Nov 10, 4:36 PM ET — Revenue increased 975% YoY, but the company reported a net loss of $7.55 million, driven by higher R&D expenses.
- [Datacentrex (DTCX) Q3 2026 earnings](https://peardigitals.com/earnings/dtcx/2026-11-10/) — Nov 10, 4:35 PM ET — Adjusted EBITDA turned positive at $1.3M, supported by $2.2M in digital asset gains, while the company maintained a strong liquidity position of $29.3M.
- [Angel Studios (ANGX) Q3 2026 earnings](https://peardigitals.com/earnings/angx/2026-11-10/) — Nov 10, 4:35 PM ET — Guild revenue more than doubled year-over-year to $115.6 million, while total revenue more than doubled to $159 million; gross margin improved to 63.0% and operating loss narrowed to $10.3 million.
- [Fortitude Gold (FTCO) Q3 2026 earnings](https://peardigitals.com/earnings/ftco/2026-11-10/) — Nov 10, 4:34 PM ET — Net income turned positive to $2.0 million, supported by higher sales and gross profit, though cash balance declined.
- [North European Oil Royalty Trust (NRT) Q3 2026 earnings](https://peardigitals.com/earnings/nrt/2026-11-10/) — Nov 10, 4:30 PM ET — Revenue and distributions declined year-over-year, with the adjusted EBITDA margin contracting by 1.2 percentage points.
- [Intelligent Bio Solutions (INBS) Q1 2027 earnings](https://peardigitals.com/earnings/inbs/2026-11-10/) — Nov 10, 4:30 PM ET — Record quarterly revenue of $1.39 million, up 25% year-over-year and 21% sequentially, with gross profit margin expanding to 54.5%.
- [Amprius Technologies (AMPX) Q3 2026 earnings](https://peardigitals.com/earnings/ampx/2026-11-10/) — Nov 10, 4:28 PM ET — Revenue grew 83% YoY to $39.1 million, gross margin held steady at 27%, and the company raised its full-year revenue outlook to $145 million.
- [QUICKLOGIC (QUIK) Q3 2026 earnings](https://peardigitals.com/earnings/quik/2026-11-10/) — Nov 10, 4:28 PM ET — Revenue grew 153.2% YoY but fell 6.3% sequentially as new product sales declined.
- [Inhibikase Therapeutics (IKT) Q3 2026 earnings](https://peardigitals.com/earnings/ikt/2026-11-10/) — Nov 10, 4:28 PM ET — Net loss widened to $20.5 million despite a $50 million equity raise, driven by increased R&D spending for the Phase 3 IMPROVE-PAH study.
- [Big Sky Industrial (BSIN) Q3 2026 earnings](https://peardigitals.com/earnings/bsin/2026-11-10/) — Nov 10, 4:25 PM ET — Adjusted EBITDA loss narrowed to $0.84M, but revenue declined 8.8% YoY and cash reserves dropped 38% QoQ.
- [Palisade Bio (PALI) Q3 2026 earnings](https://peardigitals.com/earnings/pali/2026-11-10/) — Nov 10, 4:22 PM ET — Net loss widened to $14.6 million as R&D spending surged to $10.6 million to support Phase 2b enrollment, though cash reserves remain robust at $113.6 million.
- [Seer (SEER) Q3 2026 earnings](https://peardigitals.com/earnings/seer/2026-11-10/) — Nov 10, 4:22 PM ET — Revenue increased sequentially to $4.0 million, but the company cut full-year guidance to $13.5 million–$14.5 million due to extended sales cycles.
- [Swarmer (SWMR) Q3 2026 earnings](https://peardigitals.com/earnings/swmr/2026-11-10/) — Nov 10, 4:22 PM ET — Revenue grew 56% YoY to $216.4M, but the company reported a net loss of $7.3M and operating expenses of $7.5M, driven by public company costs and one-time items.
- [Marchex (MCHX) Q3 2026 earnings](https://peardigitals.com/earnings/mchx/2026-11-10/) — Nov 10, 4:20 PM ET — Returns to revenue growth and profitability with $1.3M GAAP net income and $2.4M Adjusted EBITDA, expanding margins to 15%.
- [BridgeBio Oncology Therapeutics (BBOT) Q3 2026 earnings](https://peardigitals.com/earnings/bbot/2026-11-10/) — Nov 10, 4:18 PM ET — R&D and G&A expenses decreased year-over-year, and net loss narrowed, supported by a strong balance sheet.
- [Petmed Express (PETS) Q2 2026 earnings](https://peardigitals.com/earnings/pets/2026-11-10/) — Nov 10, 4:17 PM ET — Net sales declined 19.4% YoY to $35.8M, widening the net loss to $6.4M as operating expenses remained high.
- [Core & Main (CNM) Q3 2026 earnings](https://peardigitals.com/earnings/cnm/2026-11-10/) — Nov 10, 4:16 PM ET — Preliminary Q3 sales and adjusted EBITDA are within the prior quarter's range, with net income at the low end of the range, while the company maintains its full-year outlook.
- [Netlist (NLST) Q3 2026 earnings](https://peardigitals.com/earnings/nlst/2026-11-10/) — Nov 10, 4:15 PM ET — Revenue surged 149% YoY driven by product sales and license fees, while net income swung to a $85.4M profit.
- [Precipio (PRPO) Q3 2026 earnings](https://peardigitals.com/earnings/prpo/2026-11-10/) — Nov 10, 4:15 PM ET — Record revenue and positive Adjusted EBITDA mark a strong quarter, supported by a strengthened cash position.
- [Satellogic (SATL) Q3 2026 earnings](https://peardigitals.com/earnings/satl/2026-11-10/) — Nov 10, 4:13 PM ET — Record revenue of $16.0 million, up 342% year-over-year, with a second consecutive quarter of positive Adjusted EBITDA of $1.2 million.
- [GEN Restaurant Group (GENK) Q3 2026 earnings](https://peardigitals.com/earnings/genk/2026-11-10/) — Nov 10, 4:13 PM ET — Revenue declines 3.3% as restaurant sales drop 12.7% and CPG revenue begins, but adjusted EBITDA improves sequentially and a binding letter of intent to sell restaurants advances the transformation.
- [Alto Neuroscience (ANRO) Q3 2026 earnings](https://peardigitals.com/earnings/anro/2026-11-10/) — Nov 10, 4:12 PM ET — Clinical progress on ALTO-207 and a strengthened balance sheet support the 2030 cash runway, though operating expenses have increased year-over-year.
- [Resideo Technologies (REZI) Q3 2026 earnings](https://peardigitals.com/earnings/rezi/2026-11-10/) — Nov 10, 4:12 PM ET — Adjusted EBITDA increased 6.6% year-over-year to $273.0 million, supported by solid revenue growth in the Residential Solutions segment.
- [Atara Biotherapeutics (ATRA) Q3 2026 earnings](https://peardigitals.com/earnings/atra/2026-11-10/) — Nov 10, 4:10 PM ET — Operational progress on the tab-cel BLA resubmission and continued expense reduction.
- [Lightpath Technologies (LPTH) Q1 2027 earnings](https://peardigitals.com/earnings/lpth/2026-11-10/) — Nov 10, 4:10 PM ET — Revenue grew 38% YoY to $20.8 million, gross margin expanded 1,100 bps to 41.4%, and adjusted EBITDA turned positive for the fifth consecutive quarter.
- [Nextnav (NN) Q3 2026 earnings](https://peardigitals.com/earnings/nn/2026-11-10/) — Nov 10, 4:09 PM ET — Revenue increased 42% YoY to $1.58B, but the company remains unprofitable with a net loss of $4.21B, driven by high operating expenses and a significant debt extinguishment gain.
- [SenesTech (SNES) Q3 2026 earnings](https://peardigitals.com/earnings/snes/2026-11-10/) — Nov 10, 4:08 PM ET — Record revenue and gross profit milestones achieved, driven by e-commerce and subscriptions, though operating losses and cash burn persist.
- [Sky Harbour Group (SKYH) Q3 2026 earnings](https://peardigitals.com/earnings/skyh/2026-11-10/) — Nov 10, 4:08 PM ET — Record Q3 results driven by record leasing and new ground leases, with guidance revised upward for the year end.
- [National CineMedia (NCMI) Q3 2026 earnings](https://peardigitals.com/earnings/ncmi/2026-11-10/) — Nov 10, 4:08 PM ET — Revenue declined 3.2% to $61.4 million, but Adjusted OIBDA improved to $3.3 million from $10.2 million a year ago, driven by the acquisition of Captivate.
- [Fossil Group (FOSL) Q3 2026 earnings](https://peardigitals.com/earnings/fosl/2026-11-10/) — Nov 10, 4:08 PM ET — Reported sales grew 0.4% while gross margin expanded 10.8 percentage points to 59.8%, driving operating income to $25.3 million and a 9.3% margin.
- [GLADSTONE LAND (LAND) Q3 2026 earnings](https://peardigitals.com/earnings/land/2026-11-10/) — Nov 10, 4:08 PM ET — Net income swung to a profit of $11.0 million, while AFFO per share more than tripled to $0.35, driven by a massive $16.8 million participation rent recognition.
- [Electromed (ELMD) Q1 2027 earnings](https://peardigitals.com/earnings/elmd/2026-11-10/) — Nov 10, 4:07 PM ET — Record Q1 FY2027 with double-digit revenue growth and a 30.7% increase in operating income, supported by a 80.0% gross margin.
- [Silicon Laboratories (SLAB) Q3 2026 earnings](https://peardigitals.com/earnings/slab/2026-11-10/) — Nov 10, 4:07 PM ET — Revenue grew 7% year-over-year, but adjusted EPS declined 3% due to a $0.12 per share non-recurring tax benefit in the prior year.
- [Metagenomi Therapeutics (MGX) Q3 2026 earnings](https://peardigitals.com/earnings/mgx/2026-11-10/) — Nov 10, 4:07 PM ET — R&D costs fell 31% YoY and cash runway extended to 2028 following FDA clearance of the MGX-001 IND.
- [Airgain (AIRG) Q3 2026 earnings](https://peardigitals.com/earnings/airg/2026-11-10/) — Nov 10, 4:06 PM ET — Revenue grew 12% sequentially and 9% year-over-year, with adjusted EBITDA turning positive for the second consecutive quarter.
- [Mobile Infrastructure (BEEP) Q3 2026 earnings](https://peardigitals.com/earnings/beep/2026-11-10/) — Nov 10, 4:06 PM ET — Strongest operating quarter of 2026 with acceleration in Same-Location Revenue and NOI, driven by volume gains and utilization improvements.
- [Dermata Therapeutics (DRMA) Q3 2026 earnings](https://peardigitals.com/earnings/drma/2026-11-10/) — Nov 10, 4:06 PM ET — Revenue generation begins with Tome Foundational Treatment, but cash burn accelerates as SG&A spending rises to support commercialization.
- [Fold Holdings (FLD) Q3 2026 earnings](https://peardigitals.com/earnings/fld/2026-11-10/) — Nov 10, 4:06 PM ET — Revenue declined 31% year-over-year, but operating expenses fell 21% and Adjusted EBITDA loss narrowed to $4.5 million from $5.5 million.
- [Freenome (FRNM) Q3 2026 earnings](https://peardigitals.com/earnings/frnm/2026-11-10/) — Nov 10, 4:06 PM ET — Revenue surged to $183.5M driven by a $180M milestone from the SimpleScreen CRC FDA approval, resulting in GAAP net income of $60.1M and positive free cash flow of $35.7M.
- [CoreWeave (CRWV) Q3 2026 earnings](https://peardigitals.com/earnings/crwv/2026-11-10/) — Nov 10, 4:05 PM ET — Record revenue and expanding adjusted operating margins driven by disciplined growth at scale.
- [Gain Therapeutics (GANX) Q3 2026 earnings](https://peardigitals.com/earnings/ganx/2026-11-10/) — Nov 10, 4:05 PM ET — Net loss narrowed to $0.07 per share as R&D and G&A expenses declined, though cash fell to $11.7 million.
- [Lumexa Imaging Holdings (LMRI) Q3 2026 earnings](https://peardigitals.com/earnings/lmri/2026-11-10/) — Nov 10, 4:05 PM ET — Revenue and Adjusted EBITDA grew, while GAAP net income improved from a loss to a profit driven by lower interest expense and a lower tax rate.
- [Velo3D (VELO) Q3 2026 earnings](https://peardigitals.com/earnings/velo/2026-11-10/) — Nov 10, 4:05 PM ET — Revenue up 50% YoY to $20.5M; gross margin improved to 26.5% from 3.2%; backlog $40.1M.
- [Orion180 Insurance Group (OIG) Q3 2026 earnings](https://peardigitals.com/earnings/oig/2026-11-10/) — Nov 10, 4:05 PM ET — Strong top-line growth and profitability expansion following IPO, driven by rapid premium accumulation and underwriting efficiency.
- [Sunrise Communications (SNNRF) Q3 2026 earnings](https://peardigitals.com/earnings/snnrf/2026-11-10/) — Nov 10, 4:05 PM ET — Revenue declined moderately, but operational efficiency improved and customer momentum continued, with guidance confirmed.
- [BW LPG (BWLP) Q3 2026 earnings](https://peardigitals.com/earnings/bwlp/2026-11-10/) — Nov 10, 4:05 PM ET — Q3 2026 financial results will be published on 24 November 2026.
- [Stereotaxis (STXS) Q3 2026 earnings](https://peardigitals.com/earnings/stxs/2026-11-10/) — Nov 10, 4:05 PM ET — Revenue growth accelerates to 20% YoY and 16% QoQ, but gross margin compresses to 45% and adjusted net loss widens to ($5.2)M due to acquisition integration costs.
- [Rigetti Computing (RGTI) Q3 2026 earnings](https://peardigitals.com/earnings/rgti/2026-11-10/) — Nov 10, 4:05 PM ET — Revenue fell 72% YoY to $1.41M, but the company achieved a key technology milestone of 99.5% median two-qubit gate fidelity on the 108-qubit system and signed a definitive $100M agreement with the U.S. Department of Commerce.
- [Anterix (ATEX) Q2 2027 earnings](https://peardigitals.com/earnings/atex/2026-11-10/) — Nov 10, 4:05 PM ET — Net loss of $4.99 million driven by a $6.09 million non-cash gain reversal and higher operating expenses.
- [Carlsmed (CARL) Q3 2026 earnings](https://peardigitals.com/earnings/carl/2026-11-10/) — Nov 10, 4:05 PM ET — Revenue grew 65% year-over-year to $21.6 million, and full-year guidance was raised to $78–80 million.
- [Kura Oncology (KURA) Q3 2026 earnings](https://peardigitals.com/earnings/kura/2026-11-10/) — Nov 10, 4:05 PM ET — Net product revenue grew 53% sequentially to $13.9 million; cash declined to $492.1 million as R&D and SG&A expenses increased.
- [B&G Foods (BGS) Q3 2026 earnings](https://peardigitals.com/earnings/bgs/2026-11-10/) — Nov 10, 4:05 PM ET — Net sales and base business net sales grew in Q3, and adjusted EBITDA and margin expanded, but a large non-cash impairment and higher interest expense led to a wider net loss.
- [Sea (SE) Q3 2026 earnings](https://peardigitals.com/earnings/se/2026-11-10/) — Nov 10, 4:05 PM ET — Revenue and gross profit grew 43.4% and 51.4% year-on-year, respectively, while net income rose 34.0%.
- [Braveheart Bio (BRVE) Q3 2026 earnings](https://peardigitals.com/earnings/brve/2026-11-10/) — Nov 10, 4:05 PM ET — Cash position strengthened by $414.3 million to $503.5 million, funding runway extended to 2029, despite a higher net loss driven by increased R&D and G&A expenses.
- [Capricor Therapeutics (CAPR) Q3 2026 earnings](https://peardigitals.com/earnings/capr/2026-11-10/) — Nov 10, 4:05 PM ET — Operating loss widened to $42.7M in Q3 2026 as R&D and G&A expenses increased, while cash and investments declined to $198.5M.
- [Grove Collaborative Holdings (GROV) Q3 2026 earnings](https://peardigitals.com/earnings/grov/2026-11-10/) — Nov 10, 4:05 PM ET — Sequential revenue growth resumed and Adjusted EBITDA turned positive for the fourth consecutive quarter, narrowing full-year guidance.
- [Factorial Energy (FAC) Q3 2026 earnings](https://peardigitals.com/earnings/fac/2026-11-10/) — Nov 10, 4:04 PM ET — Generated first commercial revenue and achieved 450 Wh/kg aerospace target ahead of plan.
- [TELA Bio (TELA) Q3 2026 earnings](https://peardigitals.com/earnings/tela/2026-11-10/) — Nov 10, 4:04 PM ET — Reduced adjusted EBITDA loss by 55% sequentially and 39% year-over-year while delivering sequential revenue growth in the US hernia market and continued year-over-year growth in Europe.
- [Achieve Life Sciences (ACHV) Q3 2026 earnings](https://peardigitals.com/earnings/achv/2026-11-10/) — Nov 10, 4:04 PM ET — Q3 operating loss narrowed to $12.1 million as cash increased to $201.5 million and operating expenses grew modestly.
- [Ambow Education Holding (AMBO) Q3 2026 earnings](https://peardigitals.com/earnings/ambo/2026-11-10/) — Nov 10, 4:03 PM ET — Revenue grew 21.4% YoY, but operating loss widened due to higher investment in HybriU product launches and go-to-market.
- [Grocery Outlet Holding (GO) Q3 2026 earnings](https://peardigitals.com/earnings/go/2026-11-10/) — Nov 10, 4:03 PM ET — Net sales grew 0.9% to $1.18B, and operating income swung to $24.0M from a loss, driven by a $3.6M restructuring credit.
- [Parkervision (PRKR) Q3 2026 earnings](https://peardigitals.com/earnings/prkr/2026-11-10/) — Nov 10, 4:03 PM ET — Net income turned positive to $903K for the quarter, driven by a large gain on contingent payment obligations, though cash declined and the company remains in a deficit position.
- [Bionano Genomics (BNGO) Q3 2026 earnings](https://peardigitals.com/earnings/bngo/2026-11-10/) — Nov 10, 4:03 PM ET — Revenue growth continues, but gross margin contracted 2 pp YoY and operating expenses remain high relative to sales.
- [Smart Sand (SND) Q3 2026 earnings](https://peardigitals.com/earnings/snd/2026-11-10/) — Nov 10, 4:02 PM ET — Revenue and margins declined sequentially, but operating cash flow surged and free cash flow turned positive.
- [Mercury Systems (MRCY) Q1 2027 earnings](https://peardigitals.com/earnings/mrcy/2026-11-10/) — Nov 10, 4:01 PM ET — Record Q1 bookings and revenue drove a 58.6% increase in adjusted EBITDA and a 22.3% adjusted EBITDA margin.
- [Usio (USIO) Q3 2026 earnings](https://peardigitals.com/earnings/usio/2026-11-10/) — Nov 10, 4:01 PM ET — Revenue up 12% and Adjusted EBITDA up 222% with margins expanding to 5.0%.
- [Hesai Group (HSAI) Q3 2026 earnings](https://peardigitals.com/earnings/hsai/2026-11-10/) — Nov 10, 4:01 PM ET — Core lidar business scaled profitably and SGI gained commercial momentum, delivering net income of RMB81 million and the sixth consecutive quarter of GAAP profitability.
- [Eupraxia Pharmaceuticals (EPRX) Q3 2026 earnings](https://peardigitals.com/earnings/eprx/2026-11-10/) — Nov 10, 4:01 PM ET — Net loss widened to $15.2 million driven by increased R&D and G&A costs as the Phase 2b RESOLVE trial reached target enrollment.
- [American Vanguard (AVD) Q3 2026 earnings](https://peardigitals.com/earnings/avd/2026-11-10/) — Nov 10, 4:01 PM ET — Adjusted EBITDA turned negative in Q3 despite revenue decline, driven by negative operating leverage and higher costs.
- [Clearfield (CLFD) Q4 2026 earnings](https://peardigitals.com/earnings/clfd/2026-11-10/) — Nov 10, 4:00 PM ET — Revenue grew modestly to $151.9 million; gross margin contracted to 32.0% due to higher product costs; net income fell to $2.1 million ($0.16 EPS) from $6.3 million ($0.45 EPS) in FY2025.
- [Phoenix New Media (FENG) Q3 2026 earnings](https://peardigitals.com/earnings/feng/2026-11-10/) — Nov 10, 4:00 PM ET — Revenue grew 8.3% YoY as paid services accelerated, but net loss widened to RMB24.3 million due to a RMB17.4 million swing in other income.
- [Credicorp (BAP) Q3 2026 earnings](https://peardigitals.com/earnings/bap/2026-11-10/) — Nov 10, 3:05 PM ET — Net income attributable to Credicorp reached S/1,929.4 million, up 11.0% YoY and down 2.6% QoQ, resulting in ROE of 19.9%.
- [Emera (EMA) Q3 2026 earnings](https://peardigitals.com/earnings/ema/2026-11-10/) — Nov 10, 12:36 PM ET — Adjusted net income decreased $3 million year-over-year due to higher MTM losses and transaction costs, partially offset by a gain on the sale of NMGC.
- [Alpha Pro Tech (APT) Q3 2026 earnings](https://peardigitals.com/earnings/apt/2026-11-10/) — Nov 10, 9:41 AM ET — Net sales and net income increased 12.3% and 97.2% respectively, with gross margin expanding 2.1 pp to 41.8%.
- [SOL Strategies (STKE) Q4 2026 earnings](https://peardigitals.com/earnings/stke/2026-11-10/) — Nov 10, 8:54 AM ET — Houdini Swap delivered strong initial operating performance with a 56% EBITDA margin and 37% volume growth, while core staking and validation income declined.
- [Veradermics (MANE) Q3 2026 earnings](https://peardigitals.com/earnings/mane/2026-11-10/) — Nov 10, 8:54 AM ET — Clinical progress in men and women supports a potential first-in-class oral treatment, but cash declined and losses widened.
- [ACCESS Newswire (ACCS) Q3 2026 earnings](https://peardigitals.com/earnings/accs/2026-11-10/) — Nov 10, 8:53 AM ET — Adjusted EBITDA margin expands to 15% and gross margin reaches 75% as operating loss narrows despite flat revenue.
- [Terrestrial Energy (IMSR) Q3 2026 earnings](https://peardigitals.com/earnings/imsr/2026-11-10/) — Nov 10, 8:43 AM ET — Operating expenses increased 12% YoY to $13.1M, widening the operating loss to $13.1M from $8.4M, while cash and cash equivalents declined 2% sequentially to $94.8M.
- [Bitdeer Technologies Group (BTDR) Q3 2026 earnings](https://peardigitals.com/earnings/btdr/2026-11-10/) — Nov 10, 8:38 AM ET — Record revenue of US$320.7 million, up 89% year-over-year, with Adjusted EBITDA of US$69.6 million, up 173%.
- [Powercompute (PWCM) Q4 2026 earnings](https://peardigitals.com/earnings/pwcm/2026-11-10/) — Nov 10, 8:29 AM ET — October production rose 20% year-over-year and 11.1% sequentially as fleet efficiency improved without adding power capacity.
- [Maxcyte (MXCT) Q3 2026 earnings](https://peardigitals.com/earnings/mxct/2026-11-10/) — Nov 10, 8:21 AM ET — Revenue growth accelerated to 49% YoY in Q3, driven by a large customer instrument purchase and SPL milestones, though operating losses widened.
- [Dominari Holdings (DOMH) Q3 2026 earnings](https://peardigitals.com/earnings/domh/2026-11-10/) — Nov 10, 8:20 AM ET — Revenue fell 69% YoY to $16.4M, but operating costs dropped 65% to $18.3M, narrowing the operating loss to $1.9M from $0.4M in the prior year.
- [KULR Technology Group (KULR) Q3 2026 earnings](https://peardigitals.com/earnings/kulr/2026-11-10/) — Nov 10, 8:15 AM ET — Revenue surged 197% to $7.4 million driven by product sales nearly quadrupling, while gross margin returned to positive territory at 4% and net income reached $4.47 million.
- [Atossa Therapeutics (ATOS) Q3 2026 earnings](https://peardigitals.com/earnings/atos/2026-11-10/) — Nov 10, 8:15 AM ET — Operating expenses declined sequentially and year-over-year, and the company secured a CVR agreement tied to a potential PRV monetization.
- [Corbus Pharmaceuticals Holdings (CRBP) Q3 2026 earnings](https://peardigitals.com/earnings/crbp/2026-11-10/) — Nov 10, 8:08 AM ET — Net loss widened to $37.8 million as a $15.0 million development milestone was incurred, offset by a slight decrease in operating expenses.
- [TriSalus Life Sciences (TLSI) Q3 2026 earnings](https://peardigitals.com/earnings/tlsi/2026-11-10/) — Nov 10, 8:06 AM ET — Revenue growth and gross margin expansion offset by higher operating losses and a revised, lower revenue guidance range.

Every release: https://peardigitals.com/earnings/sitemap.xml. One company's: https://peardigitals.com/earnings/<ticker>/.
